KACEY POE: Open Payments
NPI 1740904002 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 22 payments from 8 companies in 2025. Trend: 2023 $540 · 2024 $1,053 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $219 |
| Otsuka America Pharmaceutical, Inc. | 5 | $87 |
| Teva Pharmaceuticals USA, Inc. | 2 | $64 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: CAPLYTA, REXULTI, UZEDY, Auvelity, Jornay PM, ABILIFY MAINTENA, FANAPT, COBENFY.
Industry payments across IN — which companies pay providers there.
